Arnhold LLC Boosts Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Arnhold LLC lifted its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 1.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 44,551 shares of the healthcare conglomerate’s stock after buying an additional 555 shares during the quarter. UnitedHealth Group makes up 2.2% of Arnhold LLC’s investment portfolio, making the stock its 12th largest position. Arnhold LLC’s holdings in UnitedHealth Group were worth $22,537,000 at the end of the most recent quarter.

A number of other hedge funds have also recently bought and sold shares of the company. Three Seasons Wealth LLC acquired a new position in shares of UnitedHealth Group during the 4th quarter valued at about $1,160,000. Cheviot Value Management LLC boosted its holdings in shares of UnitedHealth Group by 12.4% in the 4th quarter. Cheviot Value Management LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $541,000 after purchasing an additional 118 shares during the last quarter. Rothschild Capital Partners LLC boosted its holdings in UnitedHealth Group by 7.2% in the fourth quarter. Rothschild Capital Partners LLC now owns 17,266 shares of the healthcare conglomerate’s stock valued at $8,734,000 after acquiring an additional 1,160 shares during the last quarter. Kovitz Investment Group Partners LLC raised its holdings in shares of UnitedHealth Group by 85.0% in the 4th quarter. Kovitz Investment Group Partners LLC now owns 336,466 shares of the healthcare conglomerate’s stock worth $170,205,000 after purchasing an additional 154,565 shares during the period. Finally, Topsail Wealth Management LLC purchased a new stake in UnitedHealth Group during the fourth quarter worth approximately $597,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on UNH shares. Truist Financial decreased their target price on UnitedHealth Group from $660.00 to $580.00 and set a “buy” rating for the company in a research report on Monday. Raymond James reiterated a “strong-buy” rating and set a $540.00 price objective (down previously from $635.00) on shares of UnitedHealth Group in a research note on Monday. Argus lowered shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Monday. Erste Group Bank raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Wednesday, April 16th. Finally, KeyCorp reduced their price target on UnitedHealth Group from $650.00 to $575.00 and set an “overweight” rating for the company in a report on Monday. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have assigned a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and a consensus price target of $603.05.

View Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $424.70 on Friday. The business’s fifty day moving average price is $504.95 and its two-hundred day moving average price is $536.14. The firm has a market capitalization of $388.48 billion, a PE ratio of 27.40, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $417.12 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNHGet Free Report) last announced its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the business posted $6.91 EPS. On average, research analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.98%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is currently 35.18%.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.